Last reviewed · How we verify

NCT06906510: TMAO

Evaluation of Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease

Completed Last updated 2 April 2025
What this trial tests

trial testing Salivary and Serum TMAO Mesurement in Periodontitis in 48 participants. Completed in 23 September 2024.

Timeline
8 January 2024
Primary endpoint
14 August 2024
23 September 2024

Quick facts

Lead sponsorAnkara Medipol University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment48
Start date8 January 2024
Primary completion14 August 2024
Estimated completion23 September 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Medipol University

Who can join

Adults 18 to 65, any sex, with Periodontitis or Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Salivary and serum levels of TMAO and TNF-α can distinguish between individuals with periodontitis and periodontally healthy individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Ankara Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06906510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing